Procalcitonin to initiate or withhold antibiotics in acute respiratory tract infections
References
Additional references
Assmann SF, Pocock SJ, Enos LE, Kasten LE. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 2000;355(9209):1064‐9.
Briel M, Christ‐Crain M, Young J, Schuetz P, Huber P, Periat P, et al. Procalcitonin‐guided antibiotic use versus a standard approach for acute respiratory tract infections in primary care: study protocol for a randomised controlled trial and baseline characteristics of participating general practitioners [ISRCTN73182671]. BMC Family Practice 2005;6:34.
Brookes ST, Whitely E, Egger M, Smith GD, Mulheran PA, Peters TJ. Subgroup analyses in randomized trials: risks of subgroup‐specific analyses; power and sample size for the interaction test. Journal of Clinical Epidemiology 2004;57(3):229‐36.
Christ‐Crain M, Jaccard‐Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, et al. Effect of procalcitonin‐guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster‐randomised, single‐blinded intervention trial. Lancet 2004;363(9409):600‐7.
Christ‐Crain M, Stolz D, Bingisser R, Muller C, Miedinger D, Huber PR, et al. Procalcitonin guidance of antibiotic therapy in community‐acquired pneumonia: a randomized trial. American Journal of Respiratory and Critical Care Medicine 2006;174(1):84‐93.
Dixon RE. Economic costs of respiratory tract infections in the United States. American Journal of Medicine 1985;78(6B):45‐51.
Evans AT, Husain S, Durairaj L, Sadowski LS, Charles‐Damte M, Wang Y. Azithromycin for acute bronchitis: a randomised, double‐blind, controlled trial. Lancet 2002;359(9318):1648‐54.
Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al. A prediction rule to identify low‐risk patients with community‐acquired pneumonia. New England Journal of Medicine 1997;336(4):243‐50.
Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 1997;278(11):901‐4.
Goossens H, Ferech M, Vander Stichele R, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross‐national database study. Lancet 2005;365(9459):579‐87.
Hoare Z, Lim WS. Pneumonia: update on diagnosis and management. BMJ 2006;332(7549):1077‐9.
Little P, Williamson I, Warner G, Gould C, Gantley M, Kinmonth AL. Open randomised trial of prescribing strategies in managing sore throat. BMJ 1997;314(7082):722‐7.
Macfarlane JT, Colville A, Guion A, Macfarlane RM, Rose DH. Prospective study of aetiology and outcome of adult lower respiratory tract infections in the community. Lancet 1993;341:511‐4.
Morgenthaler NG, Struck J, Fischer‐Schulz C, Seidel‐Mueller E, Beier W, Bergmann A. Detection of procalcitonin (PCT) in healthy controls and patients with local infection by a sensitive ILMA. Clinical Laboratory 2002;48(5‐6):263‐70.
Morgenthaler NG, Struck J, Chancerelle Y, Weglohner W, Agay D, Bohuon C, et al. Production of procalcitonin (PCT) in non‐thyroidal tissue after LPS injection. Hormone and Metabolic Research 2003;35(5):290‐5.
Muller B, Becker KL, Schachinger H, Rickenbacher PR, Huber PR, Zimmerli W, et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Critical Care Medicine 2000;28(4):977‐83.
Muller B, Becker KL. Procalcitonin: how a hormone became a marker and mediator of sepsis. Swiss Medical Weekly 2001;131(41‐2):595‐602.
Muller B, Christ‐Crain M, Schuetz P. Meta‐analysis of procalcitonin for sepsis detection. Lancet Infectious Diseases 2007;7(8):498‐9; author reply 502‐3.
Nylen ES, Muller B, Becker KL, Snyder RH. The future diagnostic role of procalcitonin levels: the need for improved sensitivity. Clinical Infectious Diseases 2003;36:823‐4.
Simmonds MC, Higgins JP, Stewart LA, Tierney JF, Clarke MJ, Thompson SG. Meta‐analysis of individual patient data from randomized trials: a review of methods used in practice. Clinical Trials 2005;2(3):209‐17.
Stolz D, Christ‐Crain M, Gencay MM, Bingisser R, Huber PR, Muller B, et al. Diagnostic value of signs, symptoms and laboratory values in lower respiratory tract infection. Swiss Medical Weekly 2006;136(27‐8):434‐40.
Stolz D, Christ‐Crain M, Bingisser R, Leuppi J, Miedinger D, Muller C, et al. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin‐guidance with standard therapy. Chest 2007;131(1):9‐19.
Thompson SG, Turner RM, Warn DE. Multilevel models for meta‐analysis, and their application to absolute risk differences. Statistical Methods in Medical Research 2001;10(6):375‐92.
Turner RM, Omar RZ, Yang M, Goldstein H, Thompson SG. A multilevel model framework for meta‐analysis of clinical trials with binary outcomes. Statistics in Medicine 2000;19(24):3417‐32.
Whang KT, Steinwald PM, White JC, Nylen ES, Snider RH, Simon GL, et al. Serum calcitonin precursors in sepsis and systemic inflammation. Journal of Clinical Endocrinology and Metabolism 1998;83(9):3296‐301.
